Home News SpyGlass Pharma completes $90 Million Series C financing to advance novel treatments for glaucoma and other chronic ophthalmic diseases back to News
minute read
SpyGlass Pharma, co-founded by University of Colorado Department of Ophthalmology professor and Slater Family Endowed Chair Malik Kahook, MD, announced closing $90 million in Series C financing to help support clinical trials of its drug delivery system in the United States.
Topics: Press Coverage
1675 North Aurora Court
F731
Aurora, CO 80045
Administration: 720-848-2500
Appointments: 720-848-2020
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
